Ninfa Saunders - 01 Jan 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ John Sprague, Attorney-in-Fact
Issuer symbol
TTOO
Transactions as of
01 Jan 2022
Transactions value $
$0
Form type
4
Filing time
04 Jan 2022, 15:01:44 UTC
Previous filing
09 Aug 2021
Next filing
28 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +32.3K +141.94% 55K 01 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 +32.3K $0.00* 0 01 Jan 2022 Common Stock 32.3K Direct F1, F2
transaction TTOO Restricted Stock Units Award $0 +77.5K $0.00 77.5K 01 Jan 2022 Common Stock 77.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On January 1, 2021 the reporting person was granted 32,258 restricted stock units that vested on January 1, 2022.
F3 The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2023.